Skip to main content
. 2018 Jun 25;7(7):160. doi: 10.3390/jcm7070160

Figure 3.

Figure 3

(A) ROC curve for using PLR (platelet/lymphocyte ratio) levels in the differential diagnosis of Group 1 (lung cancer patients) and Group 2 (control cases); (B) ROC curve for using NLR (neutrophil/lymphocyte ratio) levels in the differential diagnosis of Group 1 and Group 2.